Investors are poised to add Vaxart Inc. (VXRT) Stock to their long term portfolios

Currently, Vaxart Inc. [VXRT] is trading at $1.14, up 4.59%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The VXRT shares have lost -2.56% over the last week, with a monthly amount drifted -17.99%, and not seem to be holding up well over a long-time horizon.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


On 1, December 2022, Vaxart Announces Collaborative Funding from Leading Foundation to Study Its Norovirus Vaccine Candidate in Breastfeeding Mothers. In a post published today on Yahoo Finance, Funding and support provided by Bill & Melinda Gates Foundation Study will focus on determining the ability of oral vaccine tablets to induce breast milk antibodies and transfer of antibodies to young infants.

From an analyst’s perspective:

Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on November 02, 2021, and set its price target to $15. On June 29, 2021, downgrade downgraded it’s rating to Neutral and revised its price target to $9 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $13 on June 24, 2021. Piper Sandler initiated its recommendation with a Overweight and recommended $18 as its price target on June 11, 2021. H.C. Wainwright reiterated a Buy rating for this stock on August 12, 2020, and upped its price target to $17. In a note dated July 13, 2020, B. Riley FBR initiated an Buy rating and iterated a target price of $22 on this stock.

This stock has fluctuated between a low of $1.05 and a high of $7.61 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $7.75 within the next 12 months. Vaxart Inc. [NASDAQ: VXRT] shares were valued at $1.14 at the most recent close of the market. An investor can expect a potential return of 579.82% based on the average VXRT price forecast.

Analyzing the VXRT fundamentals

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.0800 points at the first support level, and at 1.0200 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.1700, and for the 2nd resistance point, it is at 1.2000.

Vaxart Inc. [VXRT] reported earnings per share of -$0.23 for its fiscal quarter that ended on 6/29/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.21/share, meaning a difference of -$0.02 and a surprise factor of -9.50%. By comparison, the stated earnings for the previous quarter ended on 3/30/2022 were -$0.2 per share as compared to estimates of -$0.16 per share, a difference of -$0.04 representing a surprise of -25.00%.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Vaxart Inc. [NASDAQ:VXRT] is 5.50. Also, the Quick Ratio is 15.69, while the Cash Ratio stands at 15.44. Considering the valuation of this stock, the price to sales ratio is 853.72, the price to book ratio is 4.20.

Transactions by insiders

Recent insider trading involved Ahmad Fuad, Interim CFO, that happened on Jun 22 when 5000.0 shares were purchased. Director, Yedid Robert A. completed a deal on Jan 10 to sell 1500.0 shares.